Healthcare has been pushing the need for antibiotic stewardship for years as the number of antibiotic resistant superbugs continue to grow. However, it is far from a reality in practice. The other day, I found a patient who was on four antibiotics when there would have been adequate and potent coverage on just two.
The Center for Disease Control has produced a report, the first of its kind, detailing the current antibiotic resistant landscape, and the imminent danger of complete resistant to current therapies in the next 10 years.
“If we are not careful, we will soon be in a post-antibiotic era,” Dr. Tom Frieden, the CDC’s director, said in a media briefing. “And for some patients and for some microbes, we are already there.”
On the urgent threats list are:
- Carbapenem-resistant Enterobacteriaceae or CRE, a set of ICU bacteria that are resistant to almost all antibiotics. 9,000 cases.
- Antibiotic-resistant gonorrhoea, which currently only respond to one drug. 246,000 cases.
- Clostridium difficile, growing in resistance. 250,000 cases.
Beyond this, organisms such as Pseudomonas, VRE, MRSA, Candida, and TB are also showing increasing levels of resistance.